Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.24M | 28.57M | 30.47M | 21.95M | 23.01M |
| Total Receivables | 34.41M | 44.10M | 40.23M | 40.09M | 39.07M |
| Inventory | 27.23M | 26.37M | 26.56M | 27.74M | 28.11M |
| Prepaid Expenses | 4.35M | 2.79M | 3.57M | 3.54M | 4.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.62M | 4.44M | 4.80M | 4.11M | 3.77M |
| Total Current Assets | 102.85M | 106.27M | 105.63M | 97.43M | 98.26M |
|
|
|||||
| Total Current Assets | 102.85M | 106.27M | 105.63M | 97.43M | 98.26M |
| Net Property, Plant & Equipment | 30.09M | 48.11M | 31.60M | 31.84M | 31.69M |
| Long-term Investments | 186.04M | 186.86M | 189.30M | 188.49M | 188.05M |
| Goodwill | 186.04M | 186.86M | 189.30M | 188.49M | 188.05M |
| Total Other Intangibles | 78.40M | 83.35M | 89.65M | 93.27M | 97.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.85M | 3.16M | 18.67M | 19.33M | 20.34M |
| Total Assets | 419.22M | 427.75M | 434.85M | 430.35M | 435.74M |
|
|
|||||
| Total Accounts Payable | 7.46M | 4.93M | 5.25M | 5.09M | 6.27M |
| Total Accrued Expenses | 22.11M | 28.19M | 23.47M | 19.01M | 20.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.26M | 9.31M | 9.05M | 8.50M | 105.40M |
| Total Finance Division Other Current Liabilities | 19.50M | 19.47M | 16.63M | 15.69M | 17.50M |
| Total Other Current Liabilities | 19.50M | 19.47M | 16.63M | 15.69M | 17.50M |
| Total Current Liabilities | 57.32M | 61.90M | 54.40M | 48.30M | 149.49M |
|
|
|||||
| Total Current Liabilities | 57.32M | 61.90M | 54.40M | 48.30M | 149.49M |
| Long-Term Debt | 137.24M | 145.86M | 160.97M | 170.16M | 79.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.85M | 13.66M | 10.95M | 11.75M | 12.65M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.05M | 20.09M | 21.84M | 21.67M | 21.57M |
| Total Liabilities | 230.46M | 241.50M | 248.16M | 251.88M | 263.25M |
|
|
|||||
| Common Stock & APIC | 376.75M | 375.35M | 368.56M | 365.17M | 361.36M |
| Retained Earnings | -183.80M | -185.75M | -180.73M | -183.47M | -185.07M |
| Treasury Stock & Other | -4.19M | -3.36M | -1.14M | -3.23M | -3.80M |
| Total Common Equity | 188.76M | 186.25M | 186.69M | 178.47M | 172.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 188.76M | 186.25M | 186.69M | 178.47M | 172.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 188.76M | 186.25M | 186.69M | 178.47M | 172.50M |
|
|
|||||